Page 28 - Pharma Industry
Centre keen to adopt Gujarat model of SMS-alert for 'unsafe' drugs
There are 27,000 pharmacy outlets in Gujarat, they can stop selling unsafe drugs after aberrations are detected in the batch
 "Centre keen to adopt Gujarat model of SMS-alert for 'unsafe' drugs")
Indian pharma market crosses Rs 1 lakh cr MAT; growth slows
Price control, ban on fixed dose combinations cited as reasons for slower growth
 "Indian pharma market crosses Rs 1 lakh cr MAT; growth slows")
Pharma sector grows 7.7% in May; FDC ban weighs
Diabetic, neurology and cardiac segments beat overall pharma market growth by 250-700 bps, gastro and anti-infective were laggards According to data from the AIOCD-AWACS, the market research wing of the All India Organisation of Chemists and Druggists (AIOCD), the pharmaceutical market saw a growth of 7.7 per cent in May as against 3.5 per cent previous month. "We believe the impact of the FDC ban should lessen going ahead as companies launch new combinations," Religare research analyst Praful Bohra said in a report. On the other hand, the non-FDC category grew relatively better at 8.4 per cent in May as against 4.2 per cent in April, he added. The Centre recently banned 344 FDC drugs based on the findings of an expert panel. FDC drugs continued to witness weak growth, mostly in anti-infective and dermatology therapies. Therapy-wise, the anti-diabetic, neurology/CNS and cardiac segments outperformed the pharma market growth by ...
 "Pharma sector grows 7.7% in May; FDC ban weighs")
Govt taking steps to set up funds to promote pharma sector
Govt also looking at financial viability for providing Rs 200 cr each to three new bulk drug manufacturing parks
 "Govt taking steps to set up funds to promote pharma sector")
